HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hidenori Toyoda Selected Research

Tenofovir (Viread)

1/2021Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice.
1/2020Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B.
7/2018High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hidenori Toyoda Research Topics

Disease

147Hepatocellular Carcinoma (Hepatoma)
10/2022 - 03/2002
71Infections
09/2022 - 11/2002
61Chronic Hepatitis C
01/2022 - 03/2002
46Neoplasms (Cancer)
01/2022 - 11/2005
43Fibrosis (Cirrhosis)
03/2022 - 01/2006
22Liver Cirrhosis (Hepatic Cirrhosis)
02/2022 - 02/2004
21Chronic Hepatitis B
01/2022 - 07/2006
19Liver Diseases (Liver Disease)
01/2022 - 04/2011
14Hepatitis B
01/2021 - 01/2007
12Hepatitis C
01/2020 - 04/2008
11Liver Neoplasms (Liver Cancer)
08/2021 - 08/2005
10Non-alcoholic Fatty Liver Disease
11/2021 - 02/2013
8Inflammation (Inflammations)
12/2020 - 02/2004
7Neoplasm Metastasis (Metastasis)
01/2022 - 05/2004
6Hepatitis
01/2022 - 07/2006
6Chronic Hepatitis (Chronic Active Hepatitis)
12/2020 - 04/2007
5Fatty Liver
01/2022 - 02/2013
5Hemorrhage
04/2021 - 04/2008
5Carcinogenesis
12/2020 - 03/2002
4Disease Progression
01/2022 - 03/2015
4Virus Diseases (Viral Diseases)
01/2021 - 12/2009
4Anemia
05/2019 - 02/2014
4Chronic Renal Insufficiency
02/2019 - 01/2018
4Hemophilia A (Haemophilia)
03/2012 - 06/2004
3Diabetes Mellitus
10/2022 - 01/2020
3Fatigue
06/2022 - 01/2022
3Ascites
05/2022 - 12/2012
3Alcoholic Fatty Liver
01/2021 - 01/2012
3Viremia
01/2021 - 01/2007
3Persistent Infection
12/2020 - 01/2014

Drug/Important Bio-Agent (IBA)

53Antiviral Agents (Antivirals)IBA
03/2022 - 11/2007
36InterferonsIBA
01/2022 - 03/2002
27Ribavirin (Virazole)FDA LinkGeneric
05/2019 - 03/2005
26lenvatinibIBA
06/2022 - 01/2019
25AlbuminsIBA
02/2022 - 01/2016
23BilirubinIBA
01/2022 - 03/2009
21Biomarkers (Surrogate Marker)IBA
07/2022 - 12/2006
18alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2022 - 08/2005
14Tumor Biomarkers (Tumor Markers)IBA
01/2022 - 01/2006
14Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 01/2007
13Proteins (Proteins, Gene)FDA Link
05/2022 - 11/2011
12RNA (Ribonucleic Acid)IBA
12/2020 - 03/2002
12lentil lectinIBA
08/2020 - 08/2005
10Alanine Transaminase (SGPT)IBA
01/2021 - 03/2002
10Fetal Proteins (Fetoprotein)IBA
01/2021 - 09/2007
9AntigensIBA
01/2022 - 01/2016
9acarboxyprothrombin (PIVKA)IBA
01/2022 - 09/2007
9MicroRNAs (MicroRNA)IBA
12/2020 - 05/2010
8atezolizumabIBA
10/2022 - 01/2022
8Bevacizumab (Avastin)FDA Link
10/2022 - 01/2022
8GadoliniumIBA
07/2022 - 07/2011
8Pentetic Acid (DTPA)FDA LinkGeneric
07/2022 - 07/2011
8DNA (Deoxyribonucleic Acid)IBA
01/2021 - 06/2004
8Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2017 - 06/2007
7SofosbuvirIBA
03/2022 - 11/2014
7gadolinium ethoxybenzyl DTPAFDA Link
01/2021 - 07/2011
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
02/2022 - 01/2015
6Sorafenib (BAY 43-9006)FDA Link
08/2021 - 04/2013
6glecaprevir and pibrentasvirIBA
05/2020 - 01/2018
5entecavirFDA Link
12/2021 - 07/2018
5Indicators and Reagents (Reagents)IBA
02/2020 - 09/2015
5Branched-Chain Amino AcidsIBA
01/2020 - 03/2014
5asunaprevirIBA
08/2019 - 07/2016
5daclatasvirIBA
08/2019 - 07/2016
5paritaprevirIBA
04/2019 - 10/2015
5Ritonavir (Norvir)FDA Link
04/2019 - 10/2015
5ombitasvirIBA
04/2019 - 10/2015
4Immune Checkpoint InhibitorsIBA
02/2022 - 06/2020
4Transaminases (Aminotransferases)IBA
02/2022 - 01/2015
4Hepatitis B e AntigensIBA
01/2022 - 11/2018
4Serum AlbuminIBA
01/2022 - 03/2015
4tenofovir alafenamideIBA
12/2021 - 01/2021
4Hyaluronic Acid (Hyaluronan)IBA
01/2021 - 12/2012
4Tyrosine (L-Tyrosine)FDA Link
01/2020 - 09/2015
4telaprevirIBA
04/2015 - 01/2014
3C-Reactive ProteinIBA
10/2022 - 01/2022
3velpatasvirIBA
03/2022 - 07/2018
3Keratin-18 (Keratin 18)IBA
11/2021 - 01/2017
3ledipasvirIBA
03/2021 - 06/2015
3Tenofovir (Viread)FDA Link
01/2021 - 07/2018
3pibrentasvirIBA
08/2020 - 01/2018
3glecaprevirIBA
08/2020 - 01/2018
3Pharmaceutical PreparationsIBA
07/2020 - 10/2015
3Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2019
3telomerase RNA (bTR)IBA
01/2020 - 09/2015
3grazoprevirIBA
02/2019 - 04/2017
3elbasvirIBA
02/2019 - 04/2017
3perfluorobutane (AI 700)IBA
11/2016 - 09/2014
3NucleotidesIBA
06/2015 - 01/2008
3Blood Coagulation Factors (Coagulation Factor)IBA
03/2012 - 03/2005
3Lamivudine (Epivir)FDA Link
04/2010 - 04/2007
3HSP27 Heat-Shock ProteinsIBA
07/2008 - 11/2005

Therapy/Procedure

95Therapeutics
09/2022 - 03/2002
5Aftercare (After-Treatment)
01/2022 - 12/2012
5Liver Transplantation
08/2020 - 01/2014
5Renal Dialysis (Hemodialysis)
02/2019 - 07/2016
5Hepatectomy
01/2016 - 08/2008
4Duration of Therapy
08/2020 - 01/2009
4Drug Therapy (Chemotherapy)
01/2020 - 05/2004
4Radiofrequency Ablation
02/2018 - 12/2012